Beiersdorf's annual results for 2025 show solid growth despite a weaker skincare marketdriven primarily by derma and Health Carewhile NIVEA is undergoing a strategic realignment. The key points of the page are clearly structured.
📌 Core results 2025
- Group sales of € 9.9 billion, organic +2,4%.
- EBIT margin excluding special items: 14.0% (previous year 13.9%).
- Consumer sales € 8.2 billion, organic +2,5%.
- tesa sales € 1.7 billion, organic +1,8%.
- Net income for the year € 955 million, earnings per share 4,25 €.
- Dividend of € 1.00 per share proposed.
- Share buyback program of up to € 750 million for 2026-2027.
beiersdorf.de
🧴 Development of the business divisions
- NIVEA: organic +0,9%slowed by market slowdown and China restructuring.
- Derma (Eucerin, Aquaphor): +11,7%double-digit growth for the fifth year, strong innovations (e.g. Epigenetics Serum, Thiamidol).
- Health Care (Hansaplast/Elastoplast): +9,3%, one of the strongest years, successful "Second Skin Protection" range.
- La Prairie: -4,5%but recovery in Q4 (+3.8%).
beiersdorf.de
🔧 Strategic measures
- Readjustment of the NIVEA strategy:
- More balanced portfolio (face, body, deodorant).
- More local flexibility in key regions (China, USA, India, Japan, Brazil).
- Innovation pipeline will be adjusted 2026-2027.
- Focus on science-based innovations across the entire portfolio.
beiersdorf.de
📦 tesa
- Organic growth despite difficult environment +1,8%.
- Growth primarily in Electronics and Printing & Packaging.
- China and Latin America particularly strong.
beiersdorf.de
🔮 Outlook 2026
- Flat to slightly positive organic sales growth expected.
- EBIT margin slightly below previous year (rising raw material costs, exchange rates, marketing pressure).
- Q1 2026 expected to be weaker (US trade disruptions, China Travel Retail, fewer innovation contributions).
beiersdorf.de
🧭 Brief summary
Beiersdorf remains stronger than the market averagemainly thanks to Derma and Health Care. NIVEA will be strategically realigned in order to grow more strongly again. 2026 is expected to be challenging but stable.
